National Health Investors, Inc. (NYSE:NHI) Receives $73.29 Average Price Target from Analysts

Shares of National Health Investors, Inc. (NYSE:NHI) have been assigned an average rating of “Moderate Buy” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $73.29.

A number of research analysts have recently weighed in on NHI shares. Truist Financial raised their target price on National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a report on Friday, August 30th. StockNews.com lowered National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Wells Fargo & Company lowered National Health Investors from an “overweight” rating to an “equal weight” rating and lifted their price target for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. Finally, Bank of America assumed coverage on National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price target on the stock.

National Health Investors Stock Up 1.3 %

NHI stock opened at $78.45 on Thursday. National Health Investors has a twelve month low of $49.25 and a twelve month high of $86.13. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.91. The stock’s 50 day moving average is $80.65 and its 200-day moving average is $72.58. The firm has a market capitalization of $3.41 billion, a PE ratio of 26.68, a P/E/G ratio of 4.72 and a beta of 1.04.

National Health Investors (NYSE:NHI) last posted its earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share for the quarter, missing analysts’ consensus estimates of $1.10 by ($0.29). National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. The company had revenue of $84.97 million during the quarter, compared to the consensus estimate of $64.95 million. During the same quarter in the prior year, the business earned $1.06 EPS. The firm’s revenue for the quarter was up 9.1% compared to the same quarter last year. Sell-side analysts expect that National Health Investors will post 4.52 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Friday, September 27th will be paid a $0.90 dividend. The ex-dividend date is Friday, September 27th. This represents a $3.60 annualized dividend and a dividend yield of 4.59%. National Health Investors’s payout ratio is presently 122.45%.

Institutional Trading of National Health Investors

Several hedge funds have recently made changes to their positions in NHI. Strategic Financial Concepts LLC bought a new stake in shares of National Health Investors in the second quarter valued at $28,000. International Assets Investment Management LLC bought a new stake in shares of National Health Investors in the second quarter valued at $36,000. Blue Trust Inc. raised its stake in shares of National Health Investors by 2,651.9% in the second quarter. Blue Trust Inc. now owns 743 shares of the real estate investment trust’s stock valued at $47,000 after buying an additional 716 shares during the period. Harbor Capital Advisors Inc. bought a new stake in shares of National Health Investors in the third quarter valued at $70,000. Finally, USA Financial Formulas raised its stake in shares of National Health Investors by 172.8% in the third quarter. USA Financial Formulas now owns 922 shares of the real estate investment trust’s stock valued at $78,000 after buying an additional 584 shares during the period. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.